New Zealand

This self-collection research in New Zealand is led by Prof. Bev Lawton, Director, Centre for Women’s Health Research Centre, at Victoria University of Wellington, New Zealand

HPV self-collection in Te Tai Tokerau

Te Tātai Hauora o Hine, National Centre for Women’s Health Research Aotearoa, and Mahitahi Hauora Primary Health Entity are undertaking a trial implementing HPV self-testing in Te Tai Tokerau (Northland). The trial aims to test whether cervical screening coverage utilising the universal offer of HPV self- test programme approach is non-inferior to cervical screening coverage in the current cytology cervical screening programme.

The study will play a critical part in informing the transition of New Zealand’s National Cervical Screening Programme from cytology-based screening to HPV-based screening (currently scheduled for September 2023), including the option of self-test.

The New Zealand trial leverages the benefits of the canSCREEN platform, which was successfully implemented in early 2022. The canSCREEN team integrated the data and test results from the laboratory in New Zealand directly into canSCREEN with automated data population.

Digital Health - canSCREEN

How can a cancer screening register be of benefit?

  • Supports cancer screening initiatives, thereby reducing both the incidence of preventable cancers, and the mortality rates
  • Plays a key role in the reporting process to ensure the quality and safety of screening services…Read more
NZ women

The New Zealand trial has already screened many hundreds of women and is actively using the SMS and email follow-up functionality of canSCREEN to effectively communicate results and schedule follow-up treatments.

Search our site